NanoViricides, Inc.
Price Action
Technical Summary
CONSOLIDATINGNanoViricides, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 61), indicating performance broadly in line with the market. Earnings growth of 21% provides fundamental context to the price action. However, price is extended 28% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.26 | +12.42% | ABOVE |
| 50 SMA | $1.11 | +27.56% | ABOVE |
| 100 SMA | $1.11 | +28.04% | ABOVE |
| 150 SMA | $1.22 | +15.95% | ABOVE |
| 200 SMA | $1.29 | +9.89% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NNVC in an uptrend right now?
NNVC has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is NNVC overbought or oversold?
NNVC's RSI (14) is 67. The stock is in neutral territory, neither overbought nor oversold.
Is NNVC outperforming the market?
NNVC has a Relative Strength (RS) Rating of 61 out of 99. NNVC is performing about average compared to the market.
Where is NNVC in its 52-week range?
NNVC is trading at $1.42, which is 64% of its 52-week high ($2.23) and 41% above its 52-week low ($0.85).
How volatile is NNVC?
NNVC has a Beta of 1.34 and 52-week volatility of 84%. It's more volatile than the S&P 500 - expect bigger swings.